IN ASTR 001
Latest Information Update: 07 Sep 2016
At a glance
- Originator Intas Pharmaceuticals
- Class Antidepressants
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 07 Sep 2016 No development reported - Phase-III for Major depressive disorder in India (PO)